Colinz Laboratories informs about quarterly statement of investor complaints

10 Jan 2017 Evaluate

Colinz Laboratories has informed about Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The above information is a part of company’s filings submitted to BSE.

Colinz Laboratories Share Price

66.60 11.10 (20.00%)
28-Jan-2026 13:23 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1613.65
Dr. Reddys Lab 1222.45
Cipla 1315.65
Zydus Lifesciences 892.40
Lupin 2125.20
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×